Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix

Osteoarthritis and Cartilage

Volumn 17, Issue 8, 2009, Pages 971-979

  Loeser, R F ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Cartilage; Cell senescence; Chondrocyte; Oxidative stress

Indexed keywords

AGING; CARTILAGE CELL; CARTILAGE MATRIX; CELL FUNCTION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; OSTEOARTHRITIS; OXIDATIVE STRESS; PEER REVIEW; PHENOTYPE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN TARGETING; REVIEW; SENESCENCE;

AGING; ANIMALS; CARTILAGE, ARTICULAR; CHONDROCYTES; HUMANS; OSTEOARTHRITIS; OXIDATIVE STRESS;

EID: 67650383738     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2009.03.002     Document Type: Review

References (124)

1. Prevalence of disabilities and associated health conditions among adults - United States, 1999. MMWR Morb Mortal Wkly Rep 50 (2001) 120-125
2. Dillon C.F., Rasch E.K., Gu Q., and Hirsch R. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94. J Rheumatol 33 (2006) 2271-2279
3. Glasson S.S., Blanchet T.J., and Morris E.A. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage 15 (2007) 1061-1069
4. Hayflick L. Intracellular determinants of cell aging. Mech Ageing Dev 28 (1984) 177-185
5. Muller M. Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Antioxid Redox Signal 11 (2009) 59-98
6. Goyns M.H. Genes, telomeres and mammalian ageing. Mech Ageing Dev 123 (2002) 791-799
7. Itahana K., Campisi J., and Dimri G.P. Mechanisms of cellular senescence in human and mouse cells. Biogerontology 5 (2004) 1-10
8. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120 (2005) 513-522
9. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 11 (1956) 298-300
10. Schriner S.E., Linford N.J., Martin G.M., Treuting P., Ogburn C.E., Emond M., et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308 (2005) 1909-1911
11. Treuting P.M., Linford N.J., Knoblaugh S.E., Emond M.J., Morton J.F., Martin G.M., et al. Reduction of age-associated pathology in old mice by overexpression of catalase in mitochondria. J Gerontol A Biol Sci Med Sci 63 (2008) 813-822
12. Perez V.I., Van Remmen H., Bokov A., Epstein C.J., Vijg J., and Richardson A. The overexpression of major antioxidant enzymes does not extend the lifespan of mice. Aging Cell (2008)
13. Finkel T., and Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 408 (2000) 239-247
14. Kamata H., and Hirata H. Redox regulation of cellular signalling. Cell Signal 11 (1999) 1-14
15. Nishikawa T., Kukidome D., Sonoda K., Fujisawa K., Matsuhisa T., Motoshima H., et al. Impact of mitochondrial ROS production in the pathogenesis of insulin resistance. Diabetes Res Clin Pract 77 Suppl 1 (2007) S161-S164
16. Takahashi A., Ohtani N., Yamakoshi K., Iida S., Tahara H., Nakayama K., et al. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol 8 (2006) 1291-1297
17. Zhang R., and Adams P.D. Heterochromatin and its relationship to cell senescence and cancer therapy. Cell Cycle 6 (2007) 784-789
18. Campisi J., and d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8 (2007) 729-740
19. Itahana K., Campisi J., and Dimri G.P. Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol 371 (2007) 21-31
20. Severino J., Allen R.G., Balin S., Balin A., and Cristofalo V.J. Is beta-galactosidase staining a marker of senescence in vitro and in vivo?. Exp Cell Res 257 (2000) 162-171
21. Acosta J.C., O'Loghlen A., Banito A., Guijarro M.V., Augert A., Raguz S., et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133 (2008) 1006-1018
22. Wajapeyee N., Serra R.W., Zhu X., Mahalingam M., and Green M.R. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132 (2008) 363-374
23. Parsch D., Brummendorf T.H., Richter W., and Fellenberg J. Replicative aging of human articular chondrocytes during ex vivo expansion. Arthritis Rheum 46 (2002) 2911-2916
24. Martin J.A., and Buckwalter J.A. Telomere erosion and senescence in human articular cartilage chondrocytes. J Gerontol A Biol Sci Med Sci 56 (2001) B172-B179
25. Mankin H.J. Localization of tritiated thymidine in articular cartilage of rabbits. J Bone Joint Surg 45-A (1963) 529-540
26. Aigner T., Hemmel M., Neureiter D., Gebhard P.M., Zeiler G., Kirchner T., et al. Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritis human articular knee cartilage: a study of proliferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage. Arthritis Rheum 44 (2001) 1304-1312
27. Martin J.A., Klingelhutz A.J., Moussavi-Harami F., and Buckwalter J.A. Effects of oxidative damage and telomerase activity on human articular cartilage chondrocyte senescence. J Gerontol A Biol Sci Med Sci 59 (2004) 324-337
28. Yudoh K., Nguyen T., Nakamura H., Hongo-Masuko K., Kato T., and Nishioka K. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther 7 (2005) R380-R391
29. Zhai G., Aviv A., Hunter D.J., Hart D.J., Gardner J.P., Kimura M., et al. Reduction of leucocyte telomere length in radiographic hand osteoarthritis: a population-based study. Ann Rheum Dis 65 (2006) 1444-1448
30. Del Carlo Jr. M., and Loeser R.F. Increased oxidative stress with aging reduces chondrocyte survival: Correlation with intracellular glutathione levels. Arthritis Rheum 48 (2003) 3419-3430
31. Jallali N., Ridha H., Thrasivoulou C., Underwood C., Butler P.E., and Cowen T. Vulnerability to ROS-induced cell death in ageing articular cartilage: the role of antioxidant enzyme activity. Osteoarthritis Cartilage 13 (2005) 614-622
32. Kurz B., Lemke A.K., Fay J., Pufe T., Grodzinsky A.J., and Schunke M. Pathomechanisms of cartilage destruction by mechanical injury. Ann Anat 187 (2005) 473-485
33. Davies C.M., Guilak F., Weinberg J.B., and Fermor B. Reactive nitrogen and oxygen species in interleukin-1-mediated DNA damage associated with osteoarthritis. Osteoarthritis Cartilage 16 (2008) 624-630
34. Price J.S., Waters J.G., Darrah C., Pennington C., Edwards D.R., Donell S.T., et al. The role of chondrocyte senescence in osteoarthritis. Aging Cell 1 (2002) 57-65
35. Dai S.M., Shan Z.Z., Nakamura H., Masuko-Hongo K., Kato T., Nishioka K., et al. Catabolic stress induces features of chondrocyte senescence through overexpression of caveolin 1: possible involvement of caveolin 1-induced down-regulation of articular chondrocytes in the pathogenesis of osteoarthritis. Arthritis Rheum 54 (2006) 818-831
36. Zhou H.W., Lou S.Q., and Zhang K. Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro. Rheumatology (Oxford) 43 (2004) 555-568
37. Forsyth C.B., Cole A., Murphy G., Bienias J.L., Im H.J., and Loeser Jr. R.F. Increased matrix metalloproteinase-13 production with aging by human articular chondrocytes in response to catabolic stimuli. J Gerontol A Biol Sci Med Sci 60 (2005) 1118-1124
38. Long D., Blake S., Song X.Y., Lark M., and Loeser R.F. Human articular chondrocytes produce IL-7 and respond to IL-7 with increased production of matrix metalloproteinase-13. Arthritis Res Ther 10 (2008) R23
39. Mitchell P.G., Magna H.A., Reeves L.M., Lopresti-Morrow L.L., Yocum S.A., Rosner P.J., et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 97 (1996) 761-768
40. Billinghurst R.C., Dahlberg L., Ionescu M., Reiner A., Bourne R., Rorabeck C., et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 99 (1997) 1534-1545
41. Wu W., Billinghurst R.C., Pidoux I., Antoniou J., Zukor D., Tanzer M., et al. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Arthritis Rheum 46 (2002) 2087-2094
42. Hollander A.P., Pidoux I., Reiner A., Rorabeck C., Bourne R., and Poole A.R. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 96 (1995) 2859-2869
43. Aurich M., Poole A.R., Reiner A., Mollenhauer C., Margulis A., Kuettner K.E., et al. Matrix homeostasis in aging normal human ankle cartilage. Arthritis Rheum 46 (2002) 2903-2910
44. Mouritzen U., Christgau S., Lehmann H.J., Tanko L.B., and Christiansen C. Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index. Ann Rheum Dis 62 (2003) 332-336
45. Guerne P.A., Blanco F., Kaelin A., Desgeorges A., and Lotz M. Growth factor responsiveness of human articular chondrocytes in aging and development. Arthritis Rheum 38 (1995) 960-968
46. Martin J.A., Ellerbroek S.M., and Buckwalter J.A. Age-related decline in chondrocyte response to insulin-like growth factor-I: the role of growth factor binding proteins. J Orthop Res 15 (1997) 491-498
47. Loeser R.F., Shanker G., Carlson C.S., Gardin J.F., Shelton B.J., and Sonntag W.E. Reduction in the chondrocyte response to insulin-like growth factor 1 in aging and osteoarthritis: studies in a non-human primate model of naturally occurring disease. Arthritis Rheum 43 (2000) 2110-2120
48. Messai H., Duchossoy Y., Khatib A., Panasyuk A., and Mitrovic D.R. Articular chondrocytes from aging rats respond poorly to insulin-like growth factor-1: an altered signaling pathway. Mech Ageing Dev 115 (2000) 21-37
49. Iqbal J., Dudhia J., Bird J.L., and Bayliss M.T. Age-related effects of TGF-beta on proteoglycan synthesis in equine articular cartilage. Biochem Biophys Res Commun 274 (2000) 467-471
50. Scharstuhl A., van Beuningen H.M., Vitters E.L., van der Kraan P.M., and van den Berg W.B. Loss of transforming growth factor counteraction on interleukin 1 mediated effects in cartilage of old mice. Ann Rheum Dis 61 (2002) 1095-1098
51. Bobacz K., Gruber R., Soleiman A., Erlacher L., Smolen J.S., and Graninger W.B. Expression of bone morphogenetic protein 6 in healthy and osteoarthritic human articular chondrocytes and stimulation of matrix synthesis in vitro. Arthritis Rheum 48 (2003) 2501-2508
52. Tran-Khanh N., Hoemann C.D., McKee M.D., Henderson J.E., and Buschmann M.D. Aged bovine chondrocytes display a diminished capacity to produce a collagen-rich, mechanically functional cartilage extracellular matrix. J Orthop Res 23 (2005) 1354-1362
53. Blaney Davidson E.N., Scharstuhl A., Vitters E.L., van der Kraan P.M., and van den Berg W.B. Reduced transforming growth factor-beta signaling in cartilage of old mice: role in impaired repair capacity. Arthritis Res Ther 7 (2005) R1338-R1347
54. Chubinskaya S., Kumar B., Merrihew C., Heretis K., Rueger D.C., and Kuettner K.E. Age-related changes in cartilage endogenous osteogenic protein-1 (OP-1). Biochim Biophys Acta 1588 (2002) 126-134
55. Loeser R.F., Im H.J., Richardson B., Lu Q., and Chubinskaya S. Methylation of the OP-1 promoter: potential role in the age-related decline in OP-1 expression in cartilage. Osteoarthritis Cartilage 17 (2009) 513-517
56. Richardson B. Impact of aging on DNA methylation. Ageing Res Rev 2 (2003) 245-261
57. Poschl E., Fidler A., Schmidt B., Kallipolitou A., Schmid E., and Aigner T. DNA methylation is not likely to be responsible for aggrecan down regulation in aged or osteoarthritic cartilage. Ann Rheum Dis 64 (2005) 477-480
58. Roach H.I., Yamada N., Cheung K.S., Tilley S., Clarke N.M., Oreffo R.O., et al. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum 52 (2005) 3110-3124
59. Taniguchi N., Carames B., Ronfani L., Ulmer U., Komiya S., Bianchi M.E., et al. Aging-related loss of the chromatin protein HMGB2 in articular cartilage is linked to reduced cellularity and osteoarthritis. Proc Natl Acad Sci U S A 106 (2009) 1181-1186
60. Horton Jr. W.E., Feng L., and Adams C. Chondrocyte apoptosis in development, aging and disease. Matrix Biol 17 (1998) 107-115
61. Aigner T., Kim H.A., and Roach H.I. Apoptosis in osteoarthritis. Rheum Dis Clin North Am 30 (2004) 639-653 xi
62. Kuhn K., D'Lima D.D., Hashimoto S., and Lotz M. Cell death in cartilage. Osteoarthritis Cartilage 12 (2004) 1-16
63. Vignon E., Arlot M., Patricot L.M., and Vignon G. The cell density of human femoral head cartilage. Clin Orthop 121 (1976) 303-308
64. Adams C.S., and Horton Jr. W.E. Chondrocyte apoptosis increases with age in the articular cartilage of adult animals. Anat Rec 250 (1998) 418-425
65. Loeser R.F., and Shanker G. Autocrine stimulation by insulin-like growth factor 1 and insulin-like growth factor 2 mediates chondrocyte survival in vitro. Arthritis Rheum 43 (2000) 1552-1559
66. Yang C., Li S.W., Helminen H.J., Khillan J.S., Bao Y., and Prockop D.J. Apoptosis of chondrocytes in transgenic mice lacking collagen II. Exp Cell Res 235 (1997) 370-373
67. Pulai J.I., Del Carlo Jr. M., and Loeser R.F. The alpha5beta1 integrin provides matrix survival signals for normal and osteoarthritic human articular chondrocytes in vitro. Arthritis Rheum 46 (2002) 1528-1535
68. Kinkel M.D., Yagi R., McBurney D., Nugent A., and Horton Jr. W.E. Age-related expression patterns of Bag-1 and Bcl-2 in growth plate and articular chondrocytes. Anat Rec A Discov Mol Cell Evol Biol 279 (2004) 720-728
69. Pfeuty A., and Gueride M. Peroxide accumulation without major mitochondrial alteration in replicative senescence. FEBS Lett 468 (2000) 43-47
70. Ruiz-Romero C., Lopez-Armada M.J., and Blanco F.J. Mitochondrial proteomic characterization of human normal articular chondrocytes. Osteoarthritis Cartilage 14 (2006) 507-518
71. Ruiz-Romero C., Calamia V., Mateos J., Carreira V., Martinez-Gomariz M., Fernandez M., et al. Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance. Mol Cell Proteomics (2008)
72. Regan E., Flannelly J., Bowler R., Tran K., Nicks M., Carbone B.D., et al. Extracellular superoxide dismutase and oxidant damage in osteoarthritis. Arthritis Rheum 52 (2005) 3479-3491
73. Aigner T., Fundel K., Saas J., Gebhard P.M., Haag J., Weiss T., et al. Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum 54 (2006) 3533-3544
74. Reiter C.D., Teng R.J., and Beckman J.S. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J Biol Chem 275 (2000) 32460-32466
75. Loeser R.F., Carlson C.S., Carlo M.D., and Cole A. Detection of nitrotyrosine in aging and osteoarthritic cartilage: correlation of oxidative damage with the presence of interleukin-1beta and with chondrocyte resistance to insulin-like growth factor 1. Arthritis Rheum 46 (2002) 2349-2357
76. Studer R.K., Levicoff E., Georgescu H., Miller L., Jaffurs D., and Evans C.H. Nitric oxide inhibits chondrocyte response to IGF-I: inhibition of IGF-IRbeta tyrosine phosphorylation. Am J Physiol Cell Physiol 279 (2000) C961-C969
77. 2 dependent inhibition of proteoglycan biosynthesis. J Rheumatol 15 (1988) 670-677
78. Zhou S., Cui Z., and Urban J.P. Factors influencing the oxygen concentration gradient from the synovial surface of articular cartilage to the cartilage-bone interface: a modeling study. Arthritis Rheum 50 (2004) 3915-3924
79. Rathakrishnan C., Tiku K., Raghavan A., and Tiku M.L. Release of oxygen radicals by articular chondrocytes: a study of luminol-dependent chemiluminescence and hydrogen peroxide secretion. J Bone Miner Res 7 (1992) 1139-1148
80. Lo Y.Y., and Cruz T.F. Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J Biol Chem 270 (1995) 11727-11730
81. Lo Y.Y., Conquer J.A., Grinstein S., and Cruz T.F. Interleukin-1 beta induction of c-fos and collagenase expression in articular chondrocytes: involvement of reactive oxygen species. J Cell Biochem 69 (1998) 19-29
82. Jallali N., Ridha H., Thrasivoulou C., Butler P., and Cowen T. Modulation of intracellular reactive oxygen species level in chondrocytes by IGF-1, FGF, and TGF-beta1. Connect Tissue Res 48 (2007) 149-158
83. Del Carlo M., Schwartz D., Erickson E.A., and Loeser R.F. Endogenous production of reactive oxygen species is required for stimulation of human articular chondrocyte matrix metalloproteinase production by fibronectin fragments. Free Radic Biol Med 42 (2007) 1350-1358
84. Morita K., Miyamoto T., Fujita N., Kubota Y., Ito K., Takubo K., et al. Reactive oxygen species induce chondrocyte hypertrophy in endochondral ossification. J Exp Med 204 (2007) 1613-1623
85. Finkel T. Oxidant signals and oxidative stress. Curr Opin Cell Biol 15 (2003) 247-254
86. Yang L., Carlson S.G., McBurney D., and Horton Jr. W.E. Multiple signals induce endoplasmic reticulum stress in both primary and immortalized chondrocytes resulting in loss of differentiation, impaired cell growth, and apoptosis. J Biol Chem 280 (2005) 31156-31165
87. Yang L., McBurney D., Tang S.C., Carlson S.G., and Horton Jr. W.E. A novel role for Bcl-2 associated-athanogene-1 (Bag-1) in regulation of the endoplasmic reticulum stress response in mammalian chondrocytes. J Cell Biochem 102 (2007) 786-800
88. Hudelmaier M., Glaser C., Hohe J., Englmeier K.H., Reiser M., Putz R., et al. Age-related changes in the morphology and deformational behavior of knee joint cartilage. Arthritis Rheum 44 (2001) 2556-2561
89. Ding C., Cicuttini F., Scott F., Cooley H., and Jones G. Association between age and knee structural change: a cross sectional MRI based study. Ann Rheum Dis 64 (2005) 549-555
90. Temple M.M., Bae W.C., Chen M.Q., Lotz M., Amiel D., Coutts R.D., et al. Age- and site-associated biomechanical weakening of human articular cartilage of the femoral condyle. Osteoarthritis Cartilage 15 (2007) 1042-1052
91. Buckwalter J.A., Roughley P.J., and Rosenberg L.C. Age-related changes in cartilage proteoglycans: quantitative electron microscopic studies. Microsc Res Tech 28 (1994) 398-408
92. Dudhia J., Davidson C.M., Wells T.M., Vynios D.H., Hardingham T.E., and Bayliss M.T. Age-related changes in the content of the C-terminal region of aggrecan in human articular cartilage. Biochem J 313 Pt 3 (1996) 933-940
93. Bayliss M.T., Osborne D., Woodhouse S., and Davidson C. Sulfation of chondroitin sulfate in human articular cartilage. The effect of age, topographical position, and zone of cartilage on tissue composition. J Biol Chem 274 (1999) 15892-15900
94. Wells T., Davidson C., Morgelin M., Bird J.L., Bayliss M.T., and Dudhia J. Age-related changes in the composition, the molecular stoichiometry and the stability of proteoglycan aggregates extracted from human articular cartilage. Biochem J 370 (2003) 69-79
95. Grushko G., Schneiderman R., and Maroudas A. Some biochemical and biophysical parameters for the study of the pathogenesis of osteoarthritis: a comparison between the processes of ageing and degeneration in human hip cartilage. Connect Tissue Res 19 (1989) 149-176
96. Maroudas A., Bayliss M.T., Uchitel-Kaushansky N., Schneiderman R., and Gilav E. Aggrecan turnover in human articular cartilage: use of aspartic acid racemization as a marker of molecular age. Arch Biochem Biophys 350 (1998) 61-71
97. Verzijl N., Bank R.A., TeKoppele J.M., and DeGroot J. AGEing and osteoarthritis: a different perspective. Curr Opin Rheumatol 15 (2003) 616-622
98. Verzijl N., DeGroot J., Thorpe S.R., Bank R.A., Shaw J.N., Lyons T.J., et al. Effect of collagen turnover on the accumulation of advanced glycation endproducts. J Biol Chem 275 (2000) 39027-39031
99. DeGroot J., Verzijl N., Wenting-van Wijk M.J., Jacobs K.M., Van El B., Van Roermund P.M., et al. Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheum 50 (2004) 1207-1215
100. Bank R.A., Bayliss M.T., Lafeber F.P., Maroudas A., and Tekoppele J.M. Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage. The age-related increase in non-enzymatic glycation affects biomechanical properties of cartilage. Biochem J 330 Pt 1 (1998) 345-351
101. Verzijl N., DeGroot J., Ben Z.C., Brau-Benjamin O., Maroudas A., Bank R.A., et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum 46 (2002) 114-123
102. Chen A.C., Temple M.M., Ng D.M., Verzijl N., DeGroot J., TeKoppele J.M., et al. Induction of advanced glycation end products and alterations of the tensile properties of articular cartilage. Arthritis Rheum 46 (2002) 3212-3217
103. DeGroot J., Verzijl N., Bank R.A., Lafeber F.P., Bijlsma J.W., and TeKoppele J.M. Age-related decrease in proteoglycan synthesis of human articular chondrocytes: the role of nonenzymatic glycation. Arthritis Rheum 42 (1999) 1003-1009
104. Loeser R.F., Yammani R.R., Carlson C.S., Chen H., Cole A., Im H.J., et al. Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis. Arthritis Rheum 52 (2005) 2376-2385
105. Steenvoorden M.M., Huizinga T.W., Verzijl N., Bank R.A., Ronday H.K., Luning H.A., et al. Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis Rheum 54 (2006) 253-263
106. Cecil D.L., Johnson K., Rediske J., Lotz M., Schmidt A.M., and Terkeltaub R. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. J Immunol 175 (2005) 8296-8302
107. Yammani R.R., Carlson C.S., Bresnick A.R., and Loeser R.F. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: role of the receptor for advanced glycation end products. Arthritis Rheum 54 (2006) 2901-2911
108. Wilkins E., Dieppe P., Maddison P., and Evison G. Osteoarthritis and articular chondrocalcinosis in the elderly. Ann Rheum Dis 42 (1983) 280-284
109. Felson D.T., Anderson J.J., Naimark A., Kannel W., and Meenan R.F. The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study. J Rheumatol 16 (1989) 1241-1245
110. Rosenthal A.K., Derfus B.A., and Henry L.A. Transglutaminase activity in aging articular chondrocytes and articular cartilage vesicles. Arthritis Rheum 40 (1997) 966-970
111. Rosen F., McCabe G., Quach J., Solan J., Terkeltaub R., Seegmiller J.E., et al. Differential effects of aging on human chondrocyte responses to transforming growth factor beta: increased pyrophosphate production and decreased cell proliferation. Arthritis Rheum 40 (1997) 1275-1281
112. Doherty M., and Dieppe P. Clinical aspects of calcium pyrophosphate dihydrate crystal deposition. Rheum Dis Clin North Am 14 (1988) 395-414
113. Pelletier J.P., Martel-Pelletier J., and Abramson S.B. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 44 (2001) 1237-1247
114. Aigner T., Zien A., Gehrsitz A., Gebhard P.M., and McKenna L. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 44 (2001) 2777-2789
115. Goldring M.B., and Goldring S.R. Osteoarthritis. J Cell Physiol 213 (2007) 626-634
116. Loeser R.F. Molecular mechanisms of cartilage destruction: mechanics, inflammatory mediators, and aging collide. Arthritis Rheum 54 (2006) 1357-1360
117. Ferrucci L., Cavazzini C., Corsi A., Bartali B., Russo C.R., Lauretani F., et al. Biomarkers of frailty in older persons. J Endocrinol Invest 25 (2002) 10-15
118. Andriacchi T.P., Mundermann A., Smith R.L., Alexander E.J., Dyrby C.O., and Koo S. A framework for the in vivo pathomechanics of osteoarthritis at the knee. Ann Biomed Eng 32 (2004) 447-457
119. Lane N.E., Bloch D.A., Wood P.D., and Fries J.F. Aging, long-distance running, and the development of musculoskeletal disability. A controlled study. Am J Med 82 (1987) 772-780
120. Lane N.E., Michel B., Bjorkengren A., Oehlert J., Shi H., Bloch D.A., et al. The risk of osteoarthritis with running and aging: a 5-year longitudinal study. J Rheumatol 20 (1993) 461-468
121. Sharma L., Song J., Felson D.T., Cahue S., Shamiyeh E., and Dunlop D.D. The role of knee alignment in disease progression and functional decline in knee osteoarthritis. JAMA 286 (2001) 188-195
122. Felson D.T., Goggins J., Niu J., Zhang Y., and Hunter D.J. The effect of body weight on progression of knee osteoarthritis is dependent on alignment. Arthritis Rheum 50 (2004) 3904-3909
123. Roos H., Adalberth T., Dahlberg L., and Lohmander L.S. Osteoarthritis of the knee after injury to the anterior cruciate ligament or meniscus: the influence of time and age. Osteoarthritis Cartilage 3 (1995) 261-267
124. Bukhari M., Lunt M., Barton A., Bunn D., Silman A., and Symmons D. Increasing age at symptom onset is associated with worse radiological damage at presentation in patients with early inflammatory polyarthritis. Ann Rheum Dis 66 (2007) 389-393